Skip to main content

and
  1. No Access

    Article

    Therapie von Lebermetastasen

    Die Leber ist einer der Hauptmetastasierungsorte gastrointestinaler, aber auch anderer Malignome. Aus diesem Grunde spielt die Therapie von Lebermetastasen eine zentrale Rolle in der onkologischen Behandlung.

    PD Dr. med. Carina Riediger MSc, Jens-Peter Kühn, Mechthild Krause in Die Onkologie (2023)

  2. Article

    Open Access

    Integrated radiogenomics analyses allow for subtype classification and improved outcome prognosis of patients with locally advanced HNSCC

    Patients with locally advanced head and neck squamous cell carcinoma (HNSCC) may benefit from personalised treatment, requiring biomarkers that characterize the tumour and predict treatment response. We integr...

    Asier Rabasco Meneghetti, Alex Zwanenburg, Annett Linge in Scientific Reports (2022)

  3. Article

    Open Access

    Comparison of the composition of lymphocyte subpopulations in non-relapse and relapse patients with squamous cell carcinoma of the head and neck before, during radiochemotherapy and in the follow-up period: a multicenter prospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)

    Radiochemotherapy (RCT) has been shown to induce changes in immune cell homeostasis which might affect antitumor immune responses. In the present study, we aimed to compare the composition and kinetics of majo...

    Minli Niu, Stephanie E. Combs, Annett Linge, Mechthild Krause in Radiation Oncology (2021)

  4. Article

    Open Access

    Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

    Maja Guberina, Ali Sak, Christoph Pöttgen in The Pharmacogenomics Journal (2021)

  5. Article

    Open Access

    ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy

    Identifying patients with locally advanced head and neck carcinoma on high risk of recurrence after definitive concurrent radiochemotherapy is of key importance for the selection for consolidation therapy and ...

    Maja Guberina, Ali Sak, Christoph Pöttgen in The Pharmacogenomics Journal (2021)

  6. Article

    Open Access

    Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the ‘TOaSTT’ database

    Metastasis directed treatment (MDT) is increasingly performed with the attempt to improve outcome in non-small cell lung cancer (NSCLC) patients receiving targeted- or immunotherapy (TT/IT). This study aimed t...

    Stephanie G. C. Kroeze, Jana Schaule, Corinna Fritz, David Kaul in Radiation Oncology (2021)

  7. Article

    Open Access

    Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy

    An amendment to this paper has been published and can be accessed via the original article.

    Jana Schaule, Stephanie G. C. Kroeze, Oliver Blanck, Susanne Stera in Radiation Oncology (2020)

  8. Article

    Open Access

    2D and 3D convolutional neural networks for outcome modelling of locally advanced head and neck squamous cell carcinoma

    For treatment individualisation of patients with locally advanced head and neck squamous cell carcinoma (HNSCC) treated with primary radiochemotherapy, we explored the capabilities of different deep learning a...

    Sebastian Starke, Stefan Leger, Alex Zwanenburg, Karoline Leger in Scientific Reports (2020)

  9. Article

    Open Access

    Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy

    Melanoma patients frequently develop brain metastases. The most widely used score to predict survival is the molGPA based on a mixed treatment of stereotactic radiotherapy (SRT) and whole brain radiotherapy (W...

    Jana Schaule, Stephanie G. C. Kroeze, Oliver Blanck, Susanne Stera in Radiation Oncology (2020)

  10. Article

    Open Access

    PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives

    68Gallium prostate specific membrane antigen (PSMA) ligand positron emission tomography (PET) is an increasingly used imaging modality in prostate cancer, especially in cases of tumor recurrence after curative i....

    Sebastian Zschaeck, Fabian Lohaus, Marcus Beck, Gregor Habl in Radiation Oncology (2018)

  11. Article

    Open Access

    Impact of robust treatment planning on single- and multi-field optimized plans for proton beam therapy of unilateral head and neck target volumes

    Proton beam therapy is promising for the treatment of head and neck cancer (HNC), but it is sensitive to uncertainties in patient positioning and particle range. Studies have shown that the planning target vol...

    Macarena Cubillos-Mesías, Michael Baumann, Esther G. C. Troost in Radiation Oncology (2017)

  12. Article

    Open Access

    A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling

    Radiomics applies machine learning algorithms to quantitative imaging data to characterise the tumour phenotype and predict clinical outcome. For the development of radiomics risk models, a variety of differen...

    Stefan Leger, Alex Zwanenburg, Karoline Pilz, Fabian Lohaus in Scientific Reports (2017)